Cerebellar hematoma in severe hemophilia with inhibitor on emicizumab prophylaxis: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cerebellar hematoma in severe hemophilia with inhibitor on emicizumab prophylaxis: a case report ; volume:17 ; number:1 ; day:23 ; month:2 ; year:2023 ; pages:1-4 ; date:12.2023
Journal of medical case reports ; 17, Heft 1 (23.2.2023), 1-4, 12.2023
- Creator
-
Albattat, Sami
Alabdultaif, Abbas
Albattat, Fatimah
Albattat, Batla
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13256-023-03783-7
- URN
-
urn:nbn:de:101:1-2023041421080725654690
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Albattat, Sami
- Alabdultaif, Abbas
- Albattat, Fatimah
- Albattat, Batla
- SpringerLink (Online service)
Other Objects (12)
Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China
Pharmacokinetic model-based assessment of factor IX prophylaxis treatment regimens in severe hemophilia B
Facial Hematoma: An Atypical Bleeding Site for Acquired Hemophilia
Femoral Fractures in Severe Hemophilia
Real-world experience of emicizumab prophylaxis in Korean children with severe hemophilia A without inhibitors
Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia
Spontaneous Spinal Subdural Hematoma Secondary to Hemophilia A and Zanubrutinib
Letter to the Editor Regarding “Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China”
Adherence and Cost Effectivity of Home-Based Prophylaxis Over Institutionalized Prophylaxis in Patients with Hemophilia
Hemispheric infarct following a cerebellar hematoma: A rare coincidence
Nonacog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Moderately Severe or Severe Hemophilia B in India
Spinal subdural hematoma revealing hemophilia A in a child: A case report
Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China
Pharmacokinetic model-based assessment of factor IX prophylaxis treatment regimens in severe hemophilia B
Facial Hematoma: An Atypical Bleeding Site for Acquired Hemophilia
Femoral Fractures in Severe Hemophilia
Real-world experience of emicizumab prophylaxis in Korean children with severe hemophilia A without inhibitors
Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia
Spontaneous Spinal Subdural Hematoma Secondary to Hemophilia A and Zanubrutinib
Letter to the Editor Regarding “Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China”
Adherence and Cost Effectivity of Home-Based Prophylaxis Over Institutionalized Prophylaxis in Patients with Hemophilia
Hemispheric infarct following a cerebellar hematoma: A rare coincidence
Nonacog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Moderately Severe or Severe Hemophilia B in India
Spinal subdural hematoma revealing hemophilia A in a child: A case report
Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China
Pharmacokinetic model-based assessment of factor IX prophylaxis treatment regimens in severe hemophilia B
Facial Hematoma: An Atypical Bleeding Site for Acquired Hemophilia
Femoral Fractures in Severe Hemophilia
Real-world experience of emicizumab prophylaxis in Korean children with severe hemophilia A without inhibitors
Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia
Spontaneous Spinal Subdural Hematoma Secondary to Hemophilia A and Zanubrutinib
Letter to the Editor Regarding “Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China”
Adherence and Cost Effectivity of Home-Based Prophylaxis Over Institutionalized Prophylaxis in Patients with Hemophilia
Hemispheric infarct following a cerebellar hematoma: A rare coincidence
Nonacog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Moderately Severe or Severe Hemophilia B in India